ArticleInflammation2021

PI3K/AKT/mTOR and TLR4/MyD88/NF-κB Signaling Inhibitors Attenuate Pathological Mechanisms of Allergic Asthma.

Baowei Ma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.